Rising Prevalence of Diabetes and Osteoarthritis is Escalating the Germany Peptide Therapeutics Market

The German peptide therapeutics market will see a considerable growth of 5.0% during the forecast period. As per the report published by the German Diabetes Center (DDZ), in 2019 more than 7.2% of the population in Germany suffered from diabetes, most of them suffering from Type 2 diabetes. The report estimates that the number of individuals with diabetes will increase significantly in the next two decades. 

Scientists at DDZ and the Robert Koch Institute (RKI) in Berlin predict that in 20 years from 2019, up to 12 million people in Germany could have Type 2 diabetes. If these estimates are correct, it would correspond to an increase in the number of up to 77.0% between 2015 and 2040. The rise in demand for insulin is anticipated to drive the growth of the peptide therapeutics market in Germany. 

Browse the full report description of "German Peptide Therapeutics Market Size, Share & Trends Analysis Report, By Route of Administration (Oral and Parenteral), by Application (Cancer, Metabolic Disorder, Gastrointestinal Disorders, Central Nervous System Disorders, Respiratory Disorders, and Others), Forecast 2020-2026" at https://www.omrglobal.com/industry-reports/german-peptide-therapeutics-market

Osteoarthritis is the most frequently occurring joint disorder in Germany. As per the German Health Interview and Examination Survey for Adults (DEGS1) held in 2017, 22.3% of women and 19.7% of men were suffering from osteoarthritis in Germany. Risk factors included increasing age, genetic predisposition, obesity, and overloading straining of the joints due to congenital deformities. 

The increasing prevalence of osteoarthritis in Germany and the introduction of innovative biologics for the treatment of osteoarthritis are the two key factors that contribute to the growth of the peptide therapeutics market in Germany, thus, it expects to have stable growth in the country. 

Market Coverage

Key questions addressed by the report

• What is the market growth rate during the forecast period?
• Which segment dominates the market in the base year?
• Which segment will project the fastest growth in the market during the forecast period?
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Germany Peptide Therapeutics Market – Segmentation

By Route of Administration

• Oral
• Parenteral

By Application

• Cancer
• Metabolic Disorder
• Gastrointestinal Disorders
• Central Nervous System Disorders
• Respiratory Disorders
• Others (Kidney Disorder and Autoimmune Disorder)